Olumiant® (baricitinib) – New indication
May 10, 2022 - The FDA announced the approval of Eli Lilly’s Olumiant (baricitinib), for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Top